Inventor · disambiguated record
Bruce K. Patterson
Also filed as: PATTERSON BRUCE · PATTERSON BRUCE K
25 granted patents·14 pending applications·272 citations·filing 1994–2023
95Inventor score
Top patents by PatentIndex Score
39 records- 0191US11045546B1Methods of treating coronavirus infectionCYTODYN INC·Filed 2020·Granted Jun 29, 2021·39 cites·19 claims
- 0291US7524631B2HPV E6, E7 mRNA assay and methods of use thereofPATTERSON BRUCE K·Filed 2005·Granted Apr 28, 2009·46 cites·9 claims
- 0388US11180491B2Method of treating COVID-19 by administering the CCR5/CCL5 (RANTES) interaction inhibitor maravirocINCELLDX INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 0487US7888032B2HPV E6, E7 mRNA assay and methods of use thereofINCELLDX INC·Filed 2009·Granted Feb 15, 2011·22 cites·20 claims
- 0586US12228580B2Methods of assigning a COVID pathological type based on a cytokine/chemokine panelINCELLDX INC·Filed 2022·Granted Feb 18, 2025·1 cites·13 claims
- 0684US2023287526A1HPV E6, E7 MRNA Assay and Methods of Use ThereofINCELLDX INC·Filed 2023·Application pending·0 cites
- 0783US11402391B2Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonistINCELLDX INC·Filed 2021·Granted Aug 2, 2022·1 cites·18 claims
- 0882US10782298B2Methods of detecting per cell PD-L1 expression and uses thereofINCELLDX INC·Filed 2018·Granted Sep 22, 2020·2 cites·20 claims
- 0981US6329167B1Method of testing adequacy of cells in a specimenFiled 2000·Granted Dec 11, 2001·17 cites·17 claims
- 1080US6329152B1Process for detecting low abundance RNA in intact cellsFiled 2000·Granted Dec 11, 2001·8 cites·22 claims
- 1177US6939687B2Method of testing adequacy of cells in a specimenFiled 2003·Granted Sep 6, 2005·11 cites·14 claims
- 1277US6528278B2Method of testing adequacy of cells in a specimenFiled 2001·Granted Mar 4, 2003·12 cites·20 claims
- 1377US5843640AMethod of simultaneously detecting amplified nucleic acid sequences and cellular antigens in cellsUNIV NORTHWESTERN·Filed 1995·Granted Dec 1, 1998·82 cites·17 claims
- 1476US8653250B2HPV E6, E7 MRNA assay and methods of use thereofPATTERSON BRUCE K·Filed 2009·Granted Feb 18, 2014·4 cites·6 claims
- 1575US9464332B2HPV E6, E7 MRNA assay and methods of use thereofINCELLDX INC·Filed 2014·Granted Oct 11, 2016·0 cites·10 claims
- 1674US6582901B2Cell specific anti-viral drug susceptibility test using tagged permissive target cellsFiled 2001·Granted Jun 24, 2003·2 cites·19 claims
- 1771US2018230556A1HPV E6, E7 MRNA Assay and Methods of Use ThereofINCELLDX INC·Filed 2018·Application pending·0 cites
- 1870US12298309B2Methods of assaying neoplastic and neoplasia-related cells and uses thereofINCELLDX INC·Filed 2023·Granted May 13, 2025·0 cites·12 claims
- 1970US11952373B2Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) interaction inhibitor maravirocINCELLDX INC·Filed 2021·Granted Apr 9, 2024·0 cites·14 claims
- 2067US2017067127A1HPV E6, E7 MRNA Assay and Methods of Use ThereofINCELLDX INC·Filed 2016·Application pending·0 cites
- 2166US11629196B2Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactionsINCELLDX INC·Filed 2020·Granted Apr 18, 2023·0 cites·12 claims
- 2264US2025205209A1Methods of Treating a Subject for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Compositions for Use in The SameINCELLDX INC·Filed 2023·Application pending·0 cites
- 2360US10167526B2Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cellsINCELLDX INC·Filed 2015·Granted Jan 1, 2019·0 cites·22 claims
- 2459US2024019447A1Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19INCELLDX INC·Filed 2023·Application pending·0 cites
- 2558US2003124519A1Cell specific anti-viral drug susceptibility test using tagged permissive target cellsFiled 2003·Application pending·0 cites
- 2658US2023309562A1Anti-microbial disinfectant and methods of use and production thereofPAN MICRO BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 2758US2025099444A1Methods of Treating a Subject for Long-Haul COVID-19, and Compositions for Use in the SameINCELLDX INC·Filed 2023·Application pending·0 cites
- 2858US2025205220A1Methods of Treating a Subject for Post-Treatment Lyme Disease (PTLD) and Compositions for Use in the SamePATTERSON BRUCE K·Filed 2023·Application pending·0 cites
- 2957US11726089B2Methods of assaying neoplastic and neoplasia-related cells and uses thereofINCELLDX INC·Filed 2019·Granted Aug 15, 2023·0 cites·7 claims
- 3057US10011884B2Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cellsPATTERSON BRUCE K·Filed 2011·Granted Jul 3, 2018·0 cites·29 claims
- 3154US2010234445A1Patterns of known and novel small RNAS in human cervical cancerLUI WENG ONN·Filed 2009·Application pending·0 cites
- 3248US2014199722A1Methods for determining whether a cervical cellular sample should be tested for cervical cancer, and devices and kits for practicing the sameINCELLDX INC·Filed 2014·Application pending·0 cites
- 3345US10308990B2Methods of evaluating a cellular sample for latent cellular replication competent HIV-1INCELLDX INC·Filed 2015·Granted Jun 4, 2019·0 cites·21 claims
- 3444US2022107320A1Assaying Bladder-Associated Samples, Identifying and Treating Bladder-Associated Neoplasia, and Kits for Use ThereinINCELLDX INC·Filed 2020·Application pending·0 cites
- 3544US2021341484A1Methods for Detecting Cancer-Related Cell Populations, Screening for Metastatic Cancer and Treatments ThereofINCELLDX INC·Filed 2019·Application pending·0 cites
- 3639US2012020914A1Leukemia inhibitory factor (lif) for use in repressing human papillomavirus (hpv) transcriptionBAY JOSEPH M·Filed 2011·Application pending·0 cites
- 3738US6210875B1Process of determining the efficacy of drug treatment in HIV infected subjectsUNIV NORTHWESTERN·Filed 1997·Granted Apr 3, 2001·13 cites·10 claims
- 3837US6235304B1Method of inhibition of HIV replication by leukemia inhibitory factorFiled 1999·Granted May 22, 2001·3 cites·15 claims
- 3936US5840478AMethod of detecting amplified nucleic sequences in cells by flow cytometryUNIV NORTHWESTERN·Filed 1994·Granted Nov 24, 1998·7 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Bruce K. Patterson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →